(S (NP-SBJ (NP (NN Interaction)) (PP (IN between) (NP (ADJP-COOD (ADJP (NP (NN NF-kappa) (NN B-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (NN serum) (NN response) (JJ factor-binding))) (NNS elements)))) (VP (VBZ activates) (NP (DT an) (NN interleukin-2) (NN receptor) (JJ alpha-chain) (NN enhancer)) (ADVP (RB specifically)) (PP (IN in) (NP (NN T) (NNS lymphocytes)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP find) (SBAR (IN that) (S (NP-SBJ-45 (NP (DT a) (JJ short) (NN enhancer) (NN element)) (VP (VBG containing) (NP (NP (DT the) (NN NF-kappa) (NN B) (NN binding) (NN site)) (PP (IN from) (NP (NP (DT the) (NN interleukin-2) (NN receptor) (JJ alpha-chain) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))))))) (VP (VBZ is) (VP (ADVP (RB preferentially)) (VBN activated) (NP (-NONE- *-45)) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .))
(S (NP-SBJ-46 (DT The) (NN IL-2R) (NN alpha) (NN enhancer)) (VP-COOD (VP (VBZ binds) (NP (NN NF-kappa) (NN B)) (ADVP (RB poorly))) (CC and) (VP (VBZ is) (VP (ADVP (RB only) (RB weakly)) (VBN activated) (NP (-NONE- *-46)) (PP (IN by) (NP-LGS (NP (DT the) (NN NF-kappa) (NN B) (NN site)) (ADVP (RB alone))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Serum) (NN response) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SRF)) (-RRB- -RRB-))) (VP (VBZ binds) (PP (TO to) (NP (NP (DT a) (NN site)) (ADJP (JJ adjacent) (PP (TO to) (NP (NP (DT the) (NN NF-kappa) (NN B) (NN site)) (PP (IN in) (NP (DT the) (NN IL-2R) (NN enhancer)))))))))) (, ,) (CC and) (S (NP-SBJ (NP (DT both) (NNS sites)) (ADVP (RB together))) (VP (VBP have) (NP (JJ strong) (JJ transcriptional) (NN activity)) (ADVP (RB specifically)) (PP (IN in) (NP (NN T) (NNS cells))))) (. .))
(S (ADVP (RB Surprisingly)) (, ,) (NP-SBJ (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN SRF)) (VP (ADVP (RB constitutively)) (VBN expressed) (NP (-NONE- *)) (PP (IN in) (NP (NN T) (NNS cells))))))) (VP (VBP are) (ADVP-TMP (RB consistently)) (ADJP-PRD (ADJP (JJR higher)) (PP (IN than) (FRAG (PP (IN in) (NP (JJ other) (NN cell) (NNS types))))))) (. .))
(S (NP-SBJ (NP (NN Overexpression)) (PP (IN of) (NP (NN SRF))) (PP (IN in) (NP (NN B) (NNS cells)))) (VP (VBZ causes) (S (NP-SBJ (DT the) (NN IL-2R) (NN enhancer)) (VP (TO to) (VP (VB function)))) (SBAR (RB as) (RB well) (IN as) (S (NP-SBJ (PRP it)) (VP (VBZ does) (VP (NP (-NONE- *?*)) (PP (IN in) (NP (NN T) (NNS cells))))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ high) (NN level)) (PP (IN of) (NP (NP (NN SRF) (NN binding)) (PP (IN in) (NP (NN T) (NNS cells)))))) (VP (VBZ is) (ADVP (RB functionally)) (ADJP-PRD (JJ important)))))))) (. .))
